Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nancy Veulemans"'
Autor:
Jan Victor, Johan Bellemans, Daniel B.F. Saris, Hilde Vandenneucker, F. Handelberg, Frank P. Luyten, Bruno Vandekerckhove, René Verdonk, K. Gie Auw Yang, Michael Bohnsack, Miroslav Hašpl, Yves Fortems, Mislav Jelić, Toon Claes, Nancy Veulemans, Johan Vanlauwe, Jan Van Der Bauwhede, K. Frederik Almqvist, Koen Lagae
Publikováno v:
The American journal of sports medicine. 36(2)
Background As the natural healing capacity of damaged articular cartilage is poor, joint surface injuries are a prime target for regenerative medicine. Characterized chondrocyte implantation uses an autologous cartilage cell therapy product that has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f56a03f55e6819bb56239f26cea39ae6
https://pubmed.ncbi.nlm.nih.gov/19251680
https://pubmed.ncbi.nlm.nih.gov/19251680
Autor:
Pirnay, Jean-Paul, Vanderkelen, Alain, De Vos, Daniel, Draye, Jean-Pierre, Rose, Thomas, Ceulemans, Carl, Ectors, Nadine, Huys, Isabelle, Jennes, Serge, Verbeken, Gilbert
Publikováno v:
Cell & Tissue Banking; Dec2013, Vol. 14 Issue 4, p525-560, 36p
Autor:
Saris, Daniel B. F., Vanlauwe, Johan, Victor, Jan, Haspl, Miroslav, Bohnsack, Michael, Fortems, Yves, Vandekerckhove, Bruno, Almqvist, K. Frederik, Claes, Toon, Handelberg, Frank, Lagae, Koen, van der Bauwhede, Jan, Vandenneucker, Hilde, Yang, K. Gie Auw, Jelic, Mislay, Verdonk, Rene, Veulemans, Nancy, Bellemans, Johan, Luyten, Frank P.
Publikováno v:
American Journal of Sports Medicine; Feb2008, Vol. 36 Issue 2, p235-246, 12p, 3 Charts, 4 Graphs
Autor:
Sheridan, Cormac
Publikováno v:
Nature Biotechnology; May2006, Vol. 24 Issue 5, p479-480, 2p, 1 Color Photograph
This is the first volume to comprehensively discuss the ethical, regulatory, and social aspects of xenotransplantation research.Organized into four parts, Xenotransplantation begins by examining ethical issues around informed consent of the potential
Autor:
David K. C. Cooper
There is a critical and continuing shortage of organs and cells from deceased human donors for the purposes of transplantation into patients with terminal organ failure. The use of organs and cells from pigs – i.e., cross-species transplantation, o